Vaxxinity, Inc. (VAXX) Financials

VAXX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 57.5 million 33.8 million
June 30, 2023 71.4 million 36.4 million
March 31, 2023 85.5 million 39.4 million
Dec. 31, 2022 106.4 million 44.2 million

VAXX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -13.3 million 1.8 million
June 30, 2023 -12.2 million 2.4 million
March 31, 2023 -20.2 million 2.2 million
Dec. 31, 2022 -14.8 million 2.4 million

VAXX Net Income

No data available :(

VAXX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 42.5 million - -
June 30, 2023 55.8 million - -
March 31, 2023 67.6 million - -
Dec. 31, 2022 86.8 million 9.9 million -

VAXX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 126.7 million
June 30, 2023 126.5 million
March 31, 2023 126.1 million
Dec. 31, 2022 125.9 million

VAXX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 127000 7.9 million 5.5 million -
June 30, 2023 90000 8.3 million 6.1 million -
March 31, 2023 172000 11.4 million 7.4 million -
Dec. 31, 2022 292000 13.0 million 7.8 million -

VAXX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 666000
June 30, 2023 - 512000
March 31, 2023 - 600000
Dec. 31, 2022 - 540000

VAXX

Price: $0

52 week price:
0.00
0.20

Earnings Per Share: -0.45 USD

P/E Ratio: -0.05

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 380403

Market Capitalization: 25357

Links: